Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mitazalimab × Gastrointestinal × Clear all

Phase

Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Gemcitabine 216 Fluorouracil 140 Oxaliplatin 131 Capecitabine 122 pembrolizumab 113 Irinotecan 108 Leucovorin 102 Bevacizumab 98 Nivolumab 80 130-nm albumin-bound paclitaxel 80 Cisplatin 79 Cetuximab 79 Radiotherapy 78 Albumin-Bound Paclitaxel 59 Sorafenib 56 Paclitaxel 51 Cyclophosphamide 50 Carboplatin 47 Magnetic Resonance Spectroscopy 41 Specimen Handling 37 Docetaxel 37 Taxes 35 Radiation 34 fludarabine 33 Erlotinib Hydrochloride 33 durvalumab 32 Ipilimumab 32 Biopsy 32 Radiosurgery 27 Folfox protocol 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05650918 2023-10-12

REACtiVe-2

Erasmus Medical Center

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡